Related Experiment Video
Updated: Jun 23, 2026
04:14
In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
Published on: October 6, 2023
Thyroid dyshormonogenesis detected through a modified perchlorate discharge test using a gamma-camera
Sami U Khan1, Aakif U Khan, Ayub Khan
1Institute of Radiotherapy and Nuclear Medicine, University Campus, Peshawar, Pakistan. drsami_k@yahoo.com
Nuclear Medicine Communications
|May 12, 2009
Summary
A modified perchlorate discharge test using a gamma-camera can easily detect dyshormonogenesis. This technique offers a reliable alternative when standard thyroid uptake probes are unavailable.
Area of Science:
- Endocrinology
- Nuclear Medicine
- Pediatric Endocrinology
Background:
- Dyshormonogenesis, a rare congenital thyroid disorder, requires accurate and accessible diagnostic tools.
- The standard perchlorate discharge test is a common method for diagnosing dyshormonogenesis.
- Availability of specialized equipment like thyroid uptake probes can be a limitation in some clinical settings.
Observation:
- The standard perchlorate discharge test was adapted using a gamma-camera instead of a gamma-probe.
- This modification aimed to simplify and improve the accessibility of dyshormonogenesis detection.
Findings:
- The gamma-camera-based perchlorate discharge test successfully identified two cases of dyshormonogenesis.
- This demonstrates the efficacy of the modified technique in diagnosing the condition.
Implications:
- The gamma-camera-based perchlorate discharge test presents an easy, reliable, and feasible diagnostic procedure.
- This method is particularly valuable in resource-limited settings where thyroid uptake probes are not available.
- It enhances the diagnostic capabilities for congenital hypothyroidism and related thyroid disorders.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...